News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Buy call on Boeing ahead of an expected cash-flow inflection over the next 12–18 months.
  • FAA approval of the 737 MAX 7 and new defense awards provide near-term catalysts for Boeing.
  • Algonquin Power's move to a regulated-only profile stabilizes cash flow and underpins a 4.6% yield.
  • Technical setup and valuation near support make Algonquin a measured swing-long with a defined stop.
  • VXUS is pitched as a tactical buy for international diversification, covering 8,700+ non-U.S. stocks and a 2.5% yield.
  • VXUS's bullish momentum and roughly 4.6M average daily volume support trade execution for retirement portfolios.

Latest Articles

Greenlane Holdings Announces Upcoming Pre-Funded Warrant Conversion and Lock-Up of Strategic Advisor Warrants

Greenlane Holdings Announces Upcoming Pre-Funded Warrant Conversion and Lock-Up of Strategic Advisor Warrants

Greenlane Holdings, Inc., a Nasdaq-listed digital asset treasury company focused on the Berachain blockchain, announced that Berachain Investment Corporation will convert a portion of its pre-funded warrants into common stock while adhering to beneficial ownership limits. Additionally, strategic advisor warrant holders from the company's recent PIP…

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Aktis Oncology announced the presentation of initial clinical imaging and dosimetry data for their radioconjugate AKY-2519 targeting B7-H3 expressing solid tumors at the 2026 ASCO Annual Meeting. The company received FDA clearance to initiate a Phase 1b clinical trial of AKY-2519 mid-2026. AKY-2519 is Aktis's second clinical-stage radioconjugate de…

Zoom COO Aparna Bawa Disposes of $1.13M in Class A Shares

Zoom COO Aparna Bawa Disposes of $1.13M in Class A Shares

Aparna Bawa, Chief Operating Officer of Zoom Communications, sold 12,886 shares of Class A common stock on April 17, 2026, in transactions totaling $1,129,109. The trades were carried out under a Rule 10b5-1 plan established June 4, 2025. The stock is trading at $90.95, roughly 10% higher over the past week, with a P/E of 14.86. Zoom recently repor…

Amazon CEO Executes $7.9M Stock Sale Amid Company Momentum

Amazon CEO Executes $7.9M Stock Sale Amid Company Momentum

Amazon Chief Executive Andrew R. Jassy sold 31,000 shares of Amazon common stock on April 17, 2026, in a transaction totaling $7,905,000 at $255.00 per share. The sale, completed under a Rule 10b5-1 trading plan adopted November 14, 2025, occurred while the stock traded close to a 52-week high and in the context of several company initiatives and a…

Key takeaways from Kevin Warsh’s Senate Banking Committee testimony

Key takeaways from Kevin Warsh’s Senate Banking Committee testimony

During a two-and-a-half hour appearance before the Senate Banking Committee, Federal Reserve chair nominee Kevin Warsh avoided directly endorsing President Donald Trump’s contention that the Fed’s policy rate is too high and should be cut. While he declined to answer certain pointed questions, Warsh set out several priorities for the Fed should he …

Toll Brothers to Acquire Private Home Builder in Northwest Arkansas

Toll Brothers to Acquire Private Home Builder in Northwest Arkansas

Toll Brothers, the US luxury homebuilder, announced a definitive agreement to acquire Buffington Homes of Arkansas, gaining a strong presence in the Fayetteville/Bentonville housing market. Buffington Homes is the largest luxury home builder in northwest Arkansas with over 1,500 lots. This acquisition supports Toll Brothers’ growth strategy, levera…

BNY Mellon Senior EVP Sells $1.71M in Shares, Retains Majority Stake

BNY Mellon Senior EVP Sells $1.71M in Shares, Retains Majority Stake

Alejandro Perez, Senior Executive Vice President at Bank of New York Mellon Corp (BK), sold 12,504 shares on April 17, 2026, for about $1,713,155 and gifted 1,000 shares to a charitable donor-advised fund. After the transactions, Perez holds 62,612.7610 shares directly and 1,806.0786 shares indirectly in a 401(k). Analysts have raised price targets…

Phreesia General Counsel Sells $55,954 in Stock Under 10b5-1 Plan

Phreesia General Counsel Sells $55,954 in Stock Under 10b5-1 Plan

Phreesia Inc.'s general counsel, Allison C. Hoffman, disposed of 6,176 shares of the company's common stock on April 20, 2026, under a Rule 10b5-1 trading plan adopted in December 2025. The sale totaled $55,954. The filing arrives as Phreesia reported slightly better-than-expected fourth-quarter fiscal 2026 revenue and adjusted EBITDA, but the comp…

BNY Mellon General Counsel Disposes of $4.09 Million in Shares

BNY Mellon General Counsel Disposes of $4.09 Million in Shares

J. Kevin McCarthy, Senior Executive Vice President and General Counsel at Bank of New York Mellon Corp, sold 30,000 shares on April 17, 2026, totaling $4,094,919. The transaction took place while the stock traded close to its 52-week high and follows several analyst price-target increases after a strong first-quarter showing.